Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Week Liechtenstein.
Press releases published on May 15, 2025
CORA Group Announces the Appointment of Beth McCoy to President of CORA Loyalty
GlobeNewswire
·
May 15, 2025
WARMINSTER, Pa., May 15, 2025 (GLOBE NEWSWIRE) -- CORA Group (“CORA”), an operating portfolio of Jonas Software, a subsidiary of Constellation Software Inc., announced today that Beth McCoy was promoted to President of CORA Loyalty, reporting to Denis …
Immutep’s Efti with KEYTRUDA® (pembrolizumab) & Chemotherapy Achieves High Response Rates in First-Line Non-Small Cell Lung Cancer
GlobeNewswire
·
May 15, 2025
Novel combination achieves 60.8% response rate and 90.2% disease control rate in first-line non-small cell lung cancer (1L NSCLC) Notably, ~92% of all evaluable patients have PD-L1 TPS <50%, including 43% with PD-L1 below 1 (TPS <1%), who represent an area …
Chemomab Therapeutics Announces First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 15, 2025
—Reported Positive 48-Week Data from SPRING Trial—Nebokitug Treatment in PSC Patients with Moderate/Advanced Disease Resulted in Continued Improvements across Key Biomarkers of Liver Injury, Inflammation and Fibrosis— —Aligned with FDA on Pathway to …
Journal of Clinical Nuclear Medicine Publishes Results of Tiziana’s Nasal Foralumab in Study Treating Moderate Alzheimer's Disease
GlobeNewswire
·
May 15, 2025
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …
Taysha Gene Therapies Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 15, 2025
Obtained written alignment from the FDA on key elements of TSHA-102 pivotal Part B trial design and next steps on enabling study initiation The FDA advised the Company to submit pivotal Part B trial protocol and associated statistical analysis plan as an …
Polpharma Group fordert dringende Maßnahmen zum Schutz eines frühzeitigen und gerechten Zugangs zu Medikamenten für europäische Patienten
GlobeNewswire
·
May 15, 2025
WARSCHAU, Polen, May 15, 2025 (GLOBE NEWSWIRE) -- Die Polpharma Group, ein führendes Pharmaunternehmen, fordert die Europäische Union nachdrücklich auf, entschlossene Maßnahmen zu ergreifen, um die Arzneimittelreform abzuschließen und die Kapazitäten …
Polpharma Group plaide en faveur d’une action urgente en vue de garantir aux patients européens un accès équitable et précoce aux médicaments
GlobeNewswire
·
May 15, 2025
VARSOVIE, Pologne, 15 mai 2025 (GLOBE NEWSWIRE) -- Polpharma Group, acteur pharmaceutique de première importance, enjoint l’Union européenne à arrêter des mesures décisives pour finaliser la réforme du secteur pharmaceutique et renforcer la capacité du …
Launch a stable income contract through the BlockchainCloudMining platform to quickly realize the diversification of cryptocurrency assets and double the wealth
GlobeNewswire
·
May 15, 2025
Miami, FL, May 15, 2025 (GLOBE NEWSWIRE) -- In 2025, the cryptocurrency market is experiencing rapid development. With the steady rise in the price of Bitcoin (BTC) and the continuous innovation of major digital currencies such as Ethereum (ETH), investor …
Echo Launches Worldwide and Starts Exclusive Public Sale for the ECHO Token
GlobeNewswire
·
May 15, 2025
Douglas, Isle of Man, May 15, 2025 (GLOBE NEWSWIRE) -- Echo, a revolutionary centralized crypto exchange, officially launched worldwide on May 15, marking a historical event for the digital asset trading landscape. On the same day, the platform started …
Abeona Therapeutics® Reports First Quarter 2025 Financial Results and Corporate Updates
GlobeNewswire
·
May 15, 2025
- Received approval by U.S. Food and Drug Administration (FDA) for ZEVASKYN™ (prademagene zamikeracel), the first and only autologous cell-based gene therapy for the treatment of wounds in adult and pediatric patients with recessive dystrophic …
Avicanna Reports Q1 2025 Results and First Profitable Quarter
GlobeNewswire
·
May 15, 2025
TORONTO, May 15, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based …
Digi Power X Reports 65% Increase in Q1 2025 Revenue Over Prior Quarter With no Long-Term Debt
GlobeNewswire
·
May 15, 2025
MIAMI, May 15, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (“Digi Power X” or the “Company”) (Nasdaq: DGXX / TSXV: DGX), a vertically integrated power infrastructure company focused on developing cutting-edge data centers for high-performance computing, is …
LeddarTech gibt Einführung von LeddarSim bekannt: Der nächste Quantensprung in der realistischen Simulation von Fahrerassistenzsystemen (Realistic Advanced Driver Assistance System, ADAS) und autonomem Fahren (Autonomous Driving, AD)
GlobeNewswire
·
May 15, 2025
QUEBEC CITY, Kanada, May 15, 2025 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. („LeddarTech“) (Nasdaq: LDTC), ein auf KI-Technologie spezialisiertes Softwareunternehmen, das für seine Innovationen im Bereich fortschrittlicher Fahrerassistenzsysteme (ADAS) …
レダーテック (LeddarTech)、LeddarSimのリリースを発表：現実的な先進運転支援システム (ADAS) と自動走行 (AD) シミュレーションにおける次の飛躍
GlobeNewswire
·
May 15, 2025
カナダ・ケベックシティ発, May 15, 2025 (GLOBE NEWSWIRE) -- 先進運転支援システム (ADAS) と自動運転 (AD) の革新で知られる、AIを活用したソフトウエア企業であるレダーテック・ホールディングス (LeddarTech® Holdings Inc.) (「レダーテック」) (NASDAQ: LDTC) は、バーチャルテストと実世界での展開のギャップを縮めることを目的に構築された次世代シミュレーションプラットフォーム、LeddarSim™のリリースを発表した。 …
LeddarTech 宣布推出 LeddarSim，实现逼真高级驾驶辅助系统和自动驾驶仿真领域的又一次重大飞跃
GlobeNewswire
·
May 15, 2025
魁北克市，加拿大, May 15, 2025 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc.（以下简称“LeddarTech”，Nasdaq：LDTC）是一家人工智能驱动的软件公司，因其在高级驾驶辅助系统 (ADAS) 和自动驾驶 (AD) 领域的创新而享有盛誉。公司现欣然宣布推出全新一代仿真平台 LeddarSim™，旨在缩小虚拟测试与实际部署之间的差距。 LeddarSim …
Surfshark expands Dedicated IP with new locations
GlobeNewswire
·
May 15, 2025
Surfshark, a cybersecurity company, expands its Dedicated IP service to seven new locations, now offering unique, static IP (Internet Protocol) addresses in 20 locations worldwide. This expansion provides users with reliable access to IP-sensitive services …
US Rare Cancer Market FDA Approved Rare Cancer Drug Clinical Trials Insight
GlobeNewswire
·
May 15, 2025
Delhi, May 15, 2025 (GLOBE NEWSWIRE) -- US Orphan Designated Drugs Market Opportunity, Drugs Sales, Price, Dosage and Clinical Trials Insight 2030 Report Offering and Highlights: US Orphan Designated Drugs Market Opportunity: > US$ 190 Billion By 2030 …
Zenas BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Updates
GlobeNewswire
·
May 15, 2025
- Topline results from pivotal Phase 3 INDIGO trial in Immunoglobulin G4-Related Disease expected around year-end 2025 - - Phase 2 MoonStone trial in Relapsing Multiple Sclerosis enrollment concluding; topline results expected early in the fourth quarter …
Kraig Biocraft Laboratories Receives Business License to Begin Operations in Cambodia
GlobeNewswire
·
May 15, 2025
ANN ARBOR, Mich., May 15, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), a world leader in spider silk technology*, announces today that it has officially received its business license to begin …
Microchip Brings Hardware Quantum Resistance to Embedded Controllers
GlobeNewswire
·
May 15, 2025
CHANDLER, Ariz., May 15, 2025 (GLOBE NEWSWIRE) -- Driven by advancements in cryptographic research and the need for stronger security measures, the National Security Agency (NSA) introduced the Commercial National Security Algorithm Suite 2.0 (CNSA 2.0) to …